Daxor Operating Income 2010-2011 | DXR

Daxor operating income from 2010 to 2011. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Daxor Annual Operating Income
(Millions of US $)
2011 $-6
2010 $-6
2009 $-5
Daxor Quarterly Operating Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.037B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Elanco Animal Health (ELAN) United States $5.940B 12.72
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00